RARE logo

RARE Income Tax

Annual Income Tax

-$1.82 M
-$7.52 M-132.04%

December 31, 2023

Summary

Performance

1-Year Change

-132.04%

3-Year Change

-251.2%

5-Year Change

-455.06%

15-Year Change

+88.73%

RARE Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

10.77%
RARE annual income tax is higher than 10.77% of companies in Healthcare sector

High & Low

All-time High

$5.70 M
RARE annual income tax is currently -132.04% below its historical high of $5.70 million

3-Year Low

-$1.82 M
RARE annual income tax is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RARE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 14, 2025
RARE next annual earnings announcement is scheduled for Feb 14, 2025

OtherRAREexpensesmetrics:

Annual Total Expenses

$1.00 B
RARE annual total expenses is $1.00 billion

Annual Operating Expenses

$958.25 M
RARE annual total operating expenses is $958.25 million

Annual Cost Of Goods Sold

$45.21 M
RARE annual cost of goods sold is $45.21 million

Annual Interest Expense

$66.00 M
RARE annual interest expense is $66.00 million

Quarterly Income Tax

$303.00 K
-$555.00 K-64.69%

September 30, 2024

Summary

Performance

3-Month Change

-64.69%

1-Year Change

-53.38%

3-Year Change

+66.48%

5-Year Change

+3.41%

RARE Quarterly Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.87%
RARE quarterly income tax is higher than 65.87% of companies in Healthcare sector

High & Low

All-time High

$6.29 M
RARE quarterly income tax is currently -95.18% below its historical high of $6.29 million

3-Year Low

-$3.70 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
RARE next earnings announcement is scheduled for Feb 14, 2025

OtherRAREexpensesmetrics:

Quarterly Total Expenses

$271.48 M
RARE quarterly total expenses is $271.48 million

Quarterly Operating Expenses

$250.46 M
RARE quarterly total operating expenses is $250.46 million

Quarterly Cost Of Goods Sold

$21.02 M
RARE quarterly cost of goods sold is $21.02 million

Quarterly Interest Expense

$15.71 M
RARE quarterly interest expense is $15.71 million

TTM Income Tax

-$2.09 M
-$347.00 K-19.95%

September 30, 2024

Summary

Performance

3-Month Change

-19.95%

1-Year Change

-589.67%

3-Year Change

-290.68%

5-Year Change

-163.54%

RARE TTM Income Tax Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.43%
RARE TTM income tax is higher than 9.43% of companies in Healthcare sector

High & Low

All-time High

$7.17 M
RARE TTM income tax is currently -129.11% below its historical high of $7.17 million

3-Year Low

-$2.09 M
RARE TTM income tax is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RARE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
RARE next earnings announcement is scheduled for Feb 14, 2025

OtherRAREexpensesmetrics:

Annual Total Expenses

$1.00 B
RARE annual total expenses is $1.00 billion

Annual Operating Expenses

$958.25 M
RARE annual total operating expenses is $958.25 million

TTM Cost Of Goods Sold

$71.89 M
RARE TTM cost of goods sold is $71.89 million

TTM Interest Expense

$64.85 M
RARE TTM interest expense is $64.85 million

Income Tax Formula

Income Tax Expense = Current Tax Expense + Deferred Tax Expense

RARE Income Tax Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-132.0%-53.4%-589.7%
3 y3 years-251.2%+66.5%-290.7%
5 y5 years-455.1%+3.4%-163.5%

RARE Income Tax Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-132.0%at low-95.2%+108.2%-129.1%at low
5 y5-year-132.0%at low-95.2%+108.2%-129.1%at low
alltimeall time-132.0%+88.7%-95.2%+101.9%-129.1%+87.1%

Ultragenyx Pharmaceutical Income Tax History

DateAnnualQuarterlyTTM
Sep 2024
-
$303.00 K(-64.7%)
-$2.09 M(+20.0%)
Jun 2024
-
$858.00 K(+88.6%)
-$1.74 M(-6.8%)
Mar 2024
-
$455.00 K(-112.3%)
-$1.86 M(+2.2%)
Dec 2023
-$1.82 M(-132.0%)
-$3.70 M(-669.5%)
-$1.82 M(-528.4%)
Sep 2023
-
$650.00 K(-11.2%)
$426.00 K(-93.0%)
Jun 2023
-
$732.00 K(+47.9%)
$6.06 M(+7.6%)
Mar 2023
-
$495.00 K(-134.1%)
$5.63 M(-1.1%)
Dec 2022
$5.70 M(+445.6%)
-$1.45 M(-123.1%)
$5.70 M(-20.5%)
Sep 2022
-
$6.29 M(+1981.8%)
$7.17 M(+574.9%)
Jun 2022
-
$302.00 K(-45.9%)
$1.06 M(-13.2%)
Mar 2022
-
$558.00 K(+2690.0%)
$1.22 M(+17.1%)
Dec 2021
$1.04 M(-13.5%)
$20.00 K(-89.0%)
$1.04 M(-4.6%)
Sep 2021
-
$182.00 K(-60.7%)
$1.09 M(-10.7%)
Jun 2021
-
$463.00 K(+22.2%)
$1.23 M(+4.1%)
Mar 2021
-
$379.00 K(+441.4%)
$1.18 M(-2.5%)
Dec 2020
$1.21 M
$70.00 K(-77.6%)
$1.21 M(-67.4%)
Sep 2020
-
$313.00 K(-24.6%)
$3.70 M(+0.5%)
Jun 2020
-
$415.00 K(+1.5%)
$3.68 M(+5.8%)
DateAnnualQuarterlyTTM
Mar 2020
-
$409.00 K(-84.0%)
$3.48 M(+5.9%)
Dec 2019
$3.28 M(+538.7%)
$2.56 M(+774.1%)
$3.28 M(+287.1%)
Sep 2019
-
$293.00 K(+37.6%)
$848.00 K(+5.7%)
Jun 2019
-
$213.00 K(-1.4%)
$802.00 K(+16.1%)
Mar 2019
-
$216.00 K(+71.4%)
$691.00 K(+34.4%)
Dec 2018
$514.00 K(-103.2%)
$126.00 K(-49.0%)
$514.00 K(-103.2%)
Sep 2018
-
$247.00 K(+142.2%)
-$15.83 M(-1.5%)
Jun 2018
-
$102.00 K(+161.5%)
-$16.07 M(-0.5%)
Mar 2018
-
$39.00 K(-100.2%)
-$16.16 M(-0.2%)
Dec 2017
-$16.20 M(<-9900.0%)
-$16.22 M(<-9900.0%)
-$16.20 M(<-9900.0%)
Sep 2017
-
$4000.00(-71.4%)
$53.00 K(+8.2%)
Jun 2017
-
$14.00 K(>+9900.0%)
$49.00 K(+40.0%)
Mar 2017
-
$0.00(-100.0%)
$35.00 K(0.0%)
Dec 2016
$35.00 K(>+9900.0%)
$35.00 K(>+9900.0%)
$35.00 K(>+9900.0%)
Sep 2016
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2016
-
$0.00
$0.00
Dec 2015
$0.00(0.0%)
-
-
Dec 2014
$0.00
-
-

FAQ

  • What is Ultragenyx Pharmaceutical annual income tax?
  • What is the all time high annual income tax for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical annual income tax year-on-year change?
  • What is Ultragenyx Pharmaceutical quarterly income tax?
  • What is the all time high quarterly income tax for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical quarterly income tax year-on-year change?
  • What is Ultragenyx Pharmaceutical TTM income tax?
  • What is the all time high TTM income tax for Ultragenyx Pharmaceutical?
  • What is Ultragenyx Pharmaceutical TTM income tax year-on-year change?

What is Ultragenyx Pharmaceutical annual income tax?

The current annual income tax of RARE is -$1.82 M

What is the all time high annual income tax for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high annual income tax is $5.70 M

What is Ultragenyx Pharmaceutical annual income tax year-on-year change?

Over the past year, RARE annual income tax has changed by -$7.52 M (-132.04%)

What is Ultragenyx Pharmaceutical quarterly income tax?

The current quarterly income tax of RARE is $303.00 K

What is the all time high quarterly income tax for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high quarterly income tax is $6.29 M

What is Ultragenyx Pharmaceutical quarterly income tax year-on-year change?

Over the past year, RARE quarterly income tax has changed by -$347.00 K (-53.38%)

What is Ultragenyx Pharmaceutical TTM income tax?

The current TTM income tax of RARE is -$2.09 M

What is the all time high TTM income tax for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical all-time high TTM income tax is $7.17 M

What is Ultragenyx Pharmaceutical TTM income tax year-on-year change?

Over the past year, RARE TTM income tax has changed by -$2.51 M (-589.67%)